Skip to main content
. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3

Ables 2000.

Methods Multicentre, randomized, parallel‐group study
Duration of the study: October 1994 to December 1996
 Patients excluded/patients randomized: 6/125 (5%)
Sample size calculation/method description: No/No
Participants Patients randomized: 125
Age (mean): 46 years (treatment group), 42 years (placebo group)
Sex: 82 men, 37 women
Inclusion criteria: trauma or surgical patients, expected length of stay > 48 hours, > 1 risk factors (e.g. central venous line, total parenteral nutrition, mechanical ventilation, antibiotics administration, etc.)
Exclusion criteria: unexpected serious adverse reaction to azole drugs, thrombocytopenia (< 5000/mm3), leucopenia (< 4000/mm3), increasing liver function tests greater than five times the upper limits of normal, pregnancy, anticipated life expectancy of less than three months, severe liver disease, current treatment with a systemic antifungal agent
 Percentage post‐surgical: > 30%
Percentage colonized with Candida at baseline: 24%
Interventions 1. Fluconazole 800 mg/day IV initially then 400 mg/day IV or orally (n = 63)
 2. Placebo (n = 62)
Duration of the intervention: until ICU discharge
Outcomes Mortality
 Proven IFI
 Suspected IFI
Proven or suspected IFI
 Proven IFI with azole‐resistant species
 Superficial FI
 Fungal colonization
 Fungal colonization with azole‐resistant species
 Adverse events requiring cessation
Follow‐up duration: until hospital discharge
Type of antifungal treatment Prophylaxis
Funding sources Quote: "This study was supported by an investigator‐initiated grant from Roerig/Pfizer"
Declaration of interest among the primary researchers Not reported
Notes Country: USA
 Setting: single hospital, adult ICU
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: “Patients meeting the eligibility criteria were randomly assigned to receive one of the following two prophylaxis regimen…”
Comment: insufficient information to make a judgement
Allocation concealment (selection bias) Unclear risk Comment: insufficient information to make a judgement
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Comment: insufficient information to make a judgement
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Comment: insufficient information to make a judgement
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Comment: missing outcome data balanced in numbers across groups, and reasons for missing outcome data unlikely to be related to true outcome
Selective reporting (reporting bias) Low risk Comment: the study protocol was not available, but it was clear that the published report included all expected outcomes
Other bias Low risk The study appeared free of other sources of bias